Pharmacovigilance Volume 2

This book discusses various topics in pharmacovigilance. The first section addresses such topics as approaches to minimize adverse drug reactions, different stakeholders and their importance in pharmaceutical policy development, changing needs for pharmacovigilance in the African region, machine lea...

Full description

Bibliographic Details
Main Author: Kothari, Charmy S.
Other Authors: Shah, Manan
Format: eBook
Language:English
Published: IntechOpen 2023
Subjects:
Online Access:
Collection: Directory of Open Access Books - Collection details see MPG.ReNa
LEADER 01849nma a2200397 u 4500
001 EB002186270
003 EBX01000000000000001323757
005 00000000000000.0
007 cr|||||||||||||||||||||
008 231103 ||| eng
020 |a 9781803561264 
020 |a 9781803561257 
020 |a intechopen.100957 
020 |a 9781803561271 
100 1 |a Kothari, Charmy S. 
245 0 0 |a Pharmacovigilance  |h Elektronische Ressource  |b Volume 2 
260 |b IntechOpen  |c 2023 
300 |a 1 electronic resource (124 p.) 
653 |a machine learning 
653 |a data mining 
653 |a supervised learning 
653 |a elderly 
653 |a mental disorders 
653 |a biosimilar 
653 |a Pharmacology / bicssc 
700 1 |a Shah, Manan 
700 1 |a Kothari, Charmy S. 
700 1 |a Shah, Manan 
041 0 7 |a eng  |2 ISO 639-2 
989 |b DOAB  |a Directory of Open Access Books 
500 |a Creative Commons (cc), https://creativecommons.org/licenses/by/3.0/ 
028 5 0 |a 10.5772/intechopen.100957 
856 4 2 |u https://directory.doabooks.org/handle/20.500.12854/113223  |z DOAB: description of the publication 
856 4 0 |u https://mts.intechopen.com/storage/books/11679/authors_book/authors_book.pdf  |7 0  |x Verlag  |3 Volltext 
082 0 |a 615 
520 |a This book discusses various topics in pharmacovigilance. The first section addresses such topics as approaches to minimize adverse drug reactions, different stakeholders and their importance in pharmaceutical policy development, changing needs for pharmacovigilance in the African region, machine learning applications in pharmacovigilance, and pharmacovigilance of biological drugs. The second section discusses signal detection, which is a promising approach that helps in the early identification of new, rare drug reactions (desired or undesired).